Viewing Study NCT04593251


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2025-12-25 @ 9:50 PM
Study NCT ID: NCT04593251
Status: COMPLETED
Last Update Posted: 2024-04-09
First Post: 2020-10-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Escalation Study to Evaluate an Experimental New Treatment (CALY-002) in Healthy Subjects and Subjects With Celiac Disease and Eosinophilic Esophagitis
Sponsor: Calypso Biotech BV
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-28
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-02
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-02
Completion Date Type: ACTUAL
First Submit Date: 2020-10-13
First Submit QC Date: None
Study First Post Date: 2020-10-19
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-08
Last Update Post Date: 2024-04-09
Last Update Post Date Type: ACTUAL